Melbourne trial tests new drug for silicosis amid rising cases
Researchers in Melbourne are trialing Infliximab, an anti-inflammatory drug, to treat silicosis, a severe lung disease. It's affecting workers exposed to engineered stone. The trial follows a surge in cases, prompting a ban on engineered...